Literature DB >> 1928969

Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs.

V S Kharasch1, T D Sweeney, J Fredberg, J Lehr, A I Damokosh, M E Avery, J D Brain.   

Abstract

Tracheal instillation of pentamidine in a surfactant vehicle may be an effective direct method of antibiotic delivery to the lungs. In 10 healthy hamsters, we compared the pulmonary distribution of 99mTc sulfur colloid (TcSC) mixed with pentamidine, using as a vehicle either surfactant (n = 5) or saline (n = 5). Each animal was instilled with 0.25 ml/kg of suspension containing 0.0018 mCi TcSC and pentamidine mixed with either surfactant or saline. After 4 h of spontaneous respiration, the lungs were excised, inflated to TLC, dried, and sliced into 3-mm cross sections from apex to base. Autoradiographs were examined to evaluate 99mTc distribution. The surfactant group had detectable radioactivity in 93% of all slices compared with 72% in the saline group (p = 0.02). Six slices per animal (43% of total) and their corresponding autoradiographs were analyzed for distribution of radioactivity. Lung slice area was determined by planimetry, and autoradiograph area was determined by video densitometry. We calculated the fraction of each lung slice with detectable radioactivity. The surfactant group had 41% of the lung slice areas exposed compared with 21% in the saline group (p = 0.02). The coefficient of variation of radioactive intensities within each slice was used as an index of spatial uniformity. There was a trend towards more uniform distribution in the surfactant group, with a narrower range of variation of intensities (1.51 to 2.56) than the saline group (1.95 to 6.47). We conclude that a surfactant vehicle significantly increases airspace deposition of TcSC and pentamidine instilled intratracheally in normal hamster lungs, and may improve uniformity of spread.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928969     DOI: 10.1164/ajrccm/144.4.909

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  18 in total

1.  Imaging the postdeposition dispersion of an inhaled surfactant aerosol.

Authors:  Timothy E Corcoran; Kristina M Thomas; Stephen Garoff; Robert D Tilton; Todd M Przybycien; Joseph M Pilewski
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-03-06       Impact factor: 2.849

2.  New targets for surfactant replacement therapy: experimental and clinical aspects.

Authors:  B Robertson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

3.  Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae.

Authors:  A van't Veen; J W Mouton; D Gommers; B Lachmann
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Lung clearance of intratracheally instilled 99mTc-tobramycin using pulmonary surfactant as vehicle.

Authors:  A Van't Veen; D Gommers; S J Verbrugge; P Wollmer; J W Mouton; P P Kooij; B Lachmann
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 5.  Seventy-Five Years of Research on Protein Binding.

Authors:  Axel Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

6.  The influence of regional deposition on the pharmacokinetics of pulmonary-delivered human growth hormone in rabbits.

Authors:  P Colthorpe; S J Farr; I J Smith; D Wyatt; G Taylor
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

7.  The pulmonary absorption of aerosolized and intratracheally instilled rhG-CSF and monoPEGylated rhG-CSF.

Authors:  R W Niven; K L Whitcomb; L Shaner; A Y Ip; O B Kinstler
Journal:  Pharm Res       Date:  1995-09       Impact factor: 4.200

Review 8.  The fate of exogenous surfactant in neonates with respiratory distress syndrome.

Authors:  M Hallman; T A Merritt; K Bry
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

9.  Antimicrobial and biophysical properties of surfactant supplemented with an antimicrobial peptide for treatment of bacterial pneumonia.

Authors:  Brandon J H Banaschewski; Edwin J A Veldhuizen; Eleonora Keating; Henk P Haagsman; Yi Y Zuo; Cory M Yamashita; Ruud A W Veldhuizen
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

10.  Pulmonary distribution of nanoceria: comparison of intratracheal, microspray instillation and dry powder insufflation.

Authors:  Ramon M Molina; Nagarjun V Konduru; Hugo Hirano; Thomas C Donaghey; Benoit Adamo; Brendan Laurenzi; Georgios Pyrgiotakis; Joseph D Brain
Journal:  Inhal Toxicol       Date:  2016-09-12       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.